Syfovre® (pegcetacoplan injection)
for Macular Degeneration

Syfovre (pegcetacoplan injection) is an FDA-approved injection used to treat geographic atrophy (GA), an advanced form of dry age-related macular degeneration (AMD). It slows GA progression and vision loss by targeting an overactive immune response. Syfovre is a complement inhibitor that blocks C3, a key protein in the immune system that, when overactive, damages retinal cells and accelerates GA.

Heart
Medication Guide Icon Medication Guide
TV Commercial Icon TV Commercial
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Macular Degeneration